Screener
BioCryst Pharmaceuticals BCRX Other operating expenses
Other operating expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther.
The source filing: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:03 PM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-012240
| Line item | Years Ended December 31, 2025 / Amount | Years Ended December 31, 2025 / Percent | Years Ended December 31, 2024 / Amount | Years Ended December 31, 2024 / Percent | Years Ended December 31, 2023 / Amount | Years Ended December 31, 2023 / Percent |
|---|---|---|---|---|---|---|
| Nontaxable or nondeductible items | ||||||
| Share-based payment awards | 4,837 | 2% | 2,780 | (3)% | 2,625 | (1)% |
| Sale of European ORLADEYO business | 3,867 | 1% | — | — | — | — |
| Other | 1,285 | — | 899 | (1)% | 388 | — |
| Changes in unrecognized tax benefits | (217) | — | 353 | — | 825 | — |
| Other adjustments | 4,927 | 2% | (107) | — | 505 | — |
| Income tax expense at effective income tax rate | $3,530 | 1% | $1,927 | (2)% | $310 | — |
| (a) For the year ended December 31, 2025, state taxes in California, Michigan, Minnesota, Kentucky, and New Jersey made up the majority (greater than 50 percent) of the tax effect in this category. For the year ended December 31, 2024, state taxes in Colorado, Illinois, Maine, Massachusetts, New Jersey, and Texas made up the majority of the tax effect in this category. For the year ended December 31, 2023, state taxes in Colorado, Illinois, Michigan, New Jersey, and Texas made up the majority of the tax effect in this category. |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is BioCryst Pharmaceuticals's other operating expenses?
- BioCryst Pharmaceuticals (BCRX) reported other operating expenses of 0% in Q4 2025.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about BioCryst Pharmaceuticals's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude